tradingkey.logo

FDA And CDC Recommend Pause In Use Of Valneva's Chikungunya Vaccine In Elderly

ReutersMay 12, 2025 6:08 AM

- Valneva SE VLS.PA:

  • PROVIDES UPDATE ON RECOMMENDED USE OF IXCHIQ® BY ELDERLY INDIVIDUALS IN THE UNITED STATES

  • FDA AND CDC RECOMMEND IXCHIQ USE FOR AGES 18 TO 60

  • EMA TEMPORARILY SUSPENDS IXCHIQ VACCINE FOR INDIVIDUALS OVER 65

  • FDA AND CDC RECOMMEND PAUSE IN USE OF VALNEVA'S CHIKUNGUNYA VACCINE IN ELDERLY

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI